The 70th Annual Meeting of the American Academy of Child & Adolescent Psychiatry (AACAP) will be held October 23–28, 2023, in New York City. Numerous current and former UCSF faculty members and trainees will take part in the event, including the following scheduled to contribute at one or more sessions:
Monday, October 23
- A. Ning Zhou, MD – Institute 1.3: Intersectional and Cultural Considerations When Working With Transgender and Gender-Diverse Youth of Color (1:00–3:00 p.m.)
- A. Ning Zhou, MD – Clinical Perspectives 11.2: A San Francisco Community Clinic Serving Queer and Trans Youth for 25 Years (4:00–6:00 p.m.)
Tuesday, October 24
- Khyati Brahmbhatt, MD (co-chair) – Committee Meeting: Physically Ill Child Committee (8:30–11:15 a.m.)
- Amanda Downey, MD (chair) – Symposium 6: Someday is Now: Urgently Needed Emerging Treatments for Anorexia Nervosa and Symposium 6.3: Psilocybin Therapy for the Treatment of Young Adults With Anorexia Nervosa: State of the Research (9:00–11:00 a.m.)
- Sasha Gorrell, PhD – Symposium 6.1: Using Neuroscience to Inform Treatment Approaches for Maladaptive Exercise in Anorexia Nervosa (9:00–11:00 a.m.)
Wednesday, October 25
- Erin Accurso, PhD; Amanda Downey, MD (presenting author) – New Research Poster 1.41: Medicaid Claims Data Reveal Medical Complexity and Racial Diversity in Eating Disorders in California (11:15 a.m.–1:15 p.m.)
- Khyati Brahmbhatt, MD (chair) – Clinical Perspectives 24: Emerging Needs in Pediatric Consultation-Liaison (CL) Psychiatry: Substance Use Disorder and Gender Dysphoria (8:00–10:00 a.m.)
- Khyati Brahmbhatt, MD (discussant) – Symposium 21: Suicide Screening and Disclosure: Current Update on Predictive Validity (4:00–6:00 p.m.)
- Julia Morgan Charalel, PhD – New Research Poster 2.18: Suicidal Ideation in Youth With and Without ADHD: Cognitive Mediators (3:30–5:30 p.m.)
- Johanna B. Folk, PhD (discussant) – Symposium 18: Trauma, Psychosis, and Systems-Involved Youth: Opportunities for Early Intervention (3:30–5:30 p.m.)
- Stephany Garcia; Cassandra Gastelum Lugo, MS; Daniel I. Lee, PhD; Michelle V. Porche, EdD; Joseph A. Spillane – New Research Poster 2.62: Understanding Privacy and Safety Concerns for Youth Mental Health Applications (3:30–5:30 p.m.)
- Maria Luisa Gorno-Tempini, MD, PhD; Nathan Morris; Christa Watson Pereira, PsyD – New Research Poster 2.34: Investigating Domain-Specific Impulsivity in Comorbid Dyslexia-ADHD (3:30–5:30 p.m.)
- Bryan H. King, MD, MBA (discussant) – Clinical Perspectives 33: Diagnosis and Management of Comorbidities in ASD (11:00 a.m.–1:00 p.m.)
Thursday, October 26
- Khyati Brahmbhatt, MD (presenting author); Tomoya Hirota, MD – Symposium 27.1: Catatonia in Inpatient Settings: A Comparative Case Series (9:00–11:00 a.m.)
- Mahmoud S. Farghal, MPH (presenting author); Chuan Mei Lee, MD, MA; Amanda León; Lillian Man, MPH; Petra Steinbuchel, MD; Juliet Yonek, PhD – New Research Poster 3.14: Pediatric Providers' Satisfaction With CAPP - A CPAP in California: A Mixed Methods Analysis (10:30 a.m.–12:30 p.m.)
- Rebecca Hu, MD (presenting author); Angela Jakary; Benjamin S. Sipes, MS; Olga Tymofiyeva, PhD; Tony T. Yang, MD, PhD – New Research Poster 3.47: Resilience and Amygdala Function in Healthy Adolescents (10:30 a.m.–12:30 p.m.)
- Chuan Mei Lee, MD, MA (presenting author); Christina Mangurian, MD, MAS; Carol Wei, MPH – New Research Poster 4.39: Need Factors Associated With Adequate Depression Treatment Utilization Among Adolescents: A Nationally Representative Analysis of the Medical Expenditures Panel Survey (MEPS) (1:00–3:00 p.m.)
- Nicholas J. Welsh, MD, MS – Clinical Perspectives 59.4: Specialized Assessment and Intervention Tools for Transgender Youth With ASD (2:30–4:30 p.m.)
Friday, October 27
- Khyati Brahmbhatt, MD – Other Programs: Delirium in the PICU: Gaining Perspectives Through a Balint Group (8:00–11:00 a.m.)
- Lauren Haack, PhD (presenting author); Michelle Nakaishi, MS, RN, CPNP, PMHS; Petra Steinbuchel, MD; Saun-Toy L. Trotter, MFT – Clinical Perspectives 67.2: Piloting a Novel School Consultation Model Embedded Within a California Pediatric Mental Health Access Program (11:00 a.m.–1:00 p.m.)
- Rebecca Hu, MD (presenting author); Angela Jakary; Benjamin S. Sipes, MS; Olga Tymofiyeva, PhD; Tony T. Yang, MD, PhD – New Research Poster 5.61: Effect of a Mindfulness Meditation-Based Intervention on Resilience in Healthy Adolescents (10:30 a.m.–12:30 p.m.)
- Jason Li, MD (co-chair); A. Ning Zhou, MD (discussant) – Clinical Perspectives 70: BIPOC LGBTQ Media Matters: Tools for Facilitating Discussions of Intersectionality and Mental Health and Clinical Perspectives 70.1: Queering the "Minority Model": Navigating LGBTQ+ and Asian American Identities in Contemporary Multimedia (2:30–4:30 p.m.)
Saturday, October 28
- Yoon Jae Cho, MD (presenting author); Jaehwa Choi, MD; Young-Shin Kim, MD, MPH, MS, PhD – New Research Poster 6.7: Resilience Amid Adversity: Unraveling the Impact of COVID-19 on Individuals With ASD (11:00 a.m.–1:00 p.m.)
- Diana G. Foster, PhD – Symposium 50.3: The Turnaway Study (8:30–10:30 a.m.)
- Rebecca Hu, MD; Angela Jakary; Benjamin S. Sipes, MS; Olga Tymofiyeva, PhD; Tony T. Yang, MD, PhD (presenting author) – New Research Poster 6.95: Structural Brain Connectivity Correlates of Suicidal Ideation in Adolescents (11:00 a.m.–1:00 p.m.)
- David Kastner, MD, PhD – Symposium 49.4: Data-Driven Methodology to Describe Behavioral Differences in SCN2A Haploinsufficient Rats (8:30–10:30 a.m.)
- Young-Shin Kim, MD, MPH, MS, PhD – New Research Poster 6.18: Online Peer Groups Improve Social Communication Skills for Individuals With ASD (11:00 a.m.–1:00 p.m.)
- Devanand S. Manoli, MD, PhD (co-chair) – Symposium 49: From Bench to Bedside: Neural, Molecular, and Genetic Mechanisms Contributing to ASD and Symposium 49.5: Genetic Models for Social Attachment Deficits in Neurodevelopmental Disorders (8:30–10:30 a.m.)
- Matthew W. State, MD, PhD (discussant) – Symposium 49: From Bench to Bedside: Neural, Molecular, and Genetic Mechanisms Contributing to ASD
- Belinda Wang, MD, PhD – Symposium 49.2: Molecular Mechanisms Mediating the Pathobiology of ASD (8:30–10:30 a.m.)
- A. Ning Zhou, MD (co-chair) – Symposium 55: Beyond the Sum of Its Parts: The Intersectionality of Chinese/Chinese American Sexual- and Gender-Minority Transitional-Aged Youth and Young Adults and Symposium 55.1: A Qualitative Exploration and New Model of Sexual Orientation Disclosure Among Gay Chinese/Chinese American Male Transitional-Aged Youth (2:00–4:00 p.m.)
All event times are listed in Eastern Daylight Time (EDT). Schedule information provided by the American Academy of Child & Adolescent Psychiatry. Conference registration is required to view presentation sessions. Presenters and presentations are subject to change without prior notice.
About UCSF Psychiatry and Behavioral Sciences
The UCSF Department of Psychiatry and Behavioral Sciences and the Langley Porter Psychiatric Institute are among the nation's foremost resources in the fields of child, adolescent, adult, and geriatric mental health. Together they constitute one of the largest departments in the UCSF School of Medicine and the UCSF Weill Institute for Neurosciences, with a mission focused on research (basic, translational, clinical), teaching, patient care, and public service.
UCSF Psychiatry and Behavioral Sciences conducts its clinical, educational, and research efforts at a variety of locations in Northern California, including the UCSF Nancy Friend Pritzker Psychiatry Building; UCSF Langley Porter Psychiatric Hospital; UCSF Medical Centers at Parnassus Heights, Mission Bay, and Mount Zion; UCSF Benioff Children’s Hospitals in San Francisco and Oakland; Zuckerberg San Francisco General Hospital and Trauma Center; the San Francisco VA Health Care System; UCSF Fresno; and numerous community-based sites around the San Francisco Bay Area.
About the UCSF Weill Institute for Neurosciences
The UCSF Weill Institute for Neurosciences, established by the extraordinary generosity of Joan and Sanford I. "Sandy" Weill, brings together world-class researchers with top-ranked physicians to solve some of the most complex challenges in the human brain.
The UCSF Weill Institute leverages UCSF’s unrivaled bench-to-bedside excellence in the neurosciences. It unites three UCSF departments—Psychiatry and Behavioral Sciences, Neurology, and Neurological Surgery—that are highly esteemed for both patient care and research, as well as the Neuroscience Graduate Program, a cross-disciplinary alliance of nearly 100 UCSF faculty members from 15 basic-science departments, as well as the UCSF Institute for Neurodegenerative Diseases, a multidisciplinary research center focused on finding effective treatments for Alzheimer’s disease, frontotemporal dementia, Parkinson’s disease, and other neurodegenerative disorders.
The University of California, San Francisco (UCSF) is exclusively focused on the health sciences and is dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. UCSF Health, which serves as UCSF’s primary academic medical center, includes top-ranked specialty hospitals and other clinical programs, and has affiliations throughout the Bay Area.